Concepedia
The American Journal of Gastroenterology · 2007 · 12 citations · 22 references
In IBS-C female patients, the administration of tegaserod improves symptom severity and is accompanied by an improvement of recto-sigmoid tone response to a meal.
22
Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial
Michael Camilleri, Allison R. Northcutt, Steven Kong et al. · The Lancet · 2000 · 558 citations
Functional Gastrointestinal Disorder, Gastrointestinal Pharmacology, Medicine +4
Altered small bowel motility in irritable bowel syndrome is correlated with symptoms
John Kellow, Sidney F. Phillips · Gastroenterology · 1987 · 470 citations · Full text
Functional Gastrointestinal Disorder, Medicine, Gastroenterology +3
Tegaserod, a 5‐HT<sub>4</sub> receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation
S. Müller‐Lissner, I. Fumagalli, Karna Dev Bardhan et al. · Alimentary Pharmacology & Therapeutics · 2001 · 464 citations · Full text
Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome
Charlene M. Prather, Michael Camilleri, Alan R. Zinsmeister et al. · Gastroenterology · 2000 · 412 citations
Functional Gastrointestinal Disorder, Gastroenterology, Orocecal Transit +4
Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5‐HT<sub>3</sub> receptor antagonist
Camilleri, Mayer, Drossman et al. · Alimentary Pharmacology & Therapeutics · 1999 · 372 citations · Full text